BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2026 3:51:54 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-21 02:03 |
|
Peer-Review Started |
|
2026-01-21 05:37 |
|
First Decision by Editorial Office Director |
|
2026-01-23 09:17 |
|
Return for Revision |
|
2026-01-23 09:17 |
|
Revised |
|
2026-01-28 18:19 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-05 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-05 09:27 |
|
Articles in Press |
|
2026-02-05 09:27 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-15 09:55 |
|
Publish the Manuscript Online |
|
2026-08-18 03:51 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Correspondence |
| Article Title |
Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nahed A Makhlouf |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nahed A Makhlouf, MD, Professor, Department of Tropical Medicine and Gastroenterology, Medical Director of Liver Transplantation Program, Al-Rajhi Liver Hospital, Faculty of Medicine, Assiut University, Assiut University Street, Assiut 71515, Egypt. nahedmak@yahoo.com |
| Key Words |
Adolescents; Hepatitis C virus; Generic; Ledipasvir; Sofosbuvir; Treatment naïve; Treatment experienced; Egypt |
| Core Tip |
Using brand forms of direct acting antivirals (DAAs) against hepatitis C virus (HCV) is limited in low- and middle-income countries. Generic forms of DAAs were widely used in adults. Few studies addressed this issue in children and adolescents in Egypt. We support the use of the generic forms of sofosbuvir/ledipasvir in HCV infected children and adolescents. |
| Publish Date |
2026-08-18 03:51 |
| Citation |
Makhlouf NA. Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt. World J Hepatol 2026; 18(8): 118661
|
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i8/118661.htm |
| DOI |
https://doi.org/10.4254/wjh.118661 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
